Skip to main content
. 2020 Spring;14(2):79–86.

Table 6.

Epilepsy characteristics in the groups

Epilepsy prevalence Refractory epilepsy Number of refractory cases
Group 1 7/15 (46%) 2/7 (28%) Asparagine synthetase deficiency
Biotinidase deficiency
Group 2 43/82 (52%) 10/43 (23%) Niemann-Pick disease type C (8)
Metachromatic leukodystrophy (1)
Juvenile GM2 gangliosidosis
Group 3 3/11 (27%) 1/3 (33%) Adrenoleukodystrophy
Group 3/18 (16%) 3/3 (100%) MEGDEL syndrome
Pyruvate dehydrogenase
Pyruvate carboxylase